Naturally Splendid (TSXV:NSP) (OTCQB:NSPDF) (Frankfurt:50N) (“Naturally Splendid” or “NSE” or “The Company”) is pleased to appoint Dr. Lorne Swetlikoff BSc., ND to its Advisory Board as Medical Advisor.

Dr. Lorne Swetlikoff, BSc., ND, is a licensed Naturopathic Physician (Bastyr University of Naturopathic Medicine in Seattle) with a Bachelor of Science Degree in Cell and Development Biology from UBC. Dr. Swetlikoff has been in practice for 24 years and has extensive experience in comprehensive patient care and naturopathic medicine through his clinics in Vancouver and Castlegar. He currently owns and operates Vancouver Naturopathic Clinic a busy, progressive and successful naturopathic practice in Vancouver.


In addition to his clinical practice, Dr. Swetlikoff served as the President of the College of Naturopathic Physicians of British Columbia from 2002 – 2011. Under the leadership of Dr. Swetlikoff, the College was able to work with the provincial government and multi-health care party negotiations to achieve ground-breaking changes in the naturopathic medical scope of practice. Naturopathic physicians in BC enjoy one of the broadest scopes of practice in North America and now have prescribing authority for conventional drugs and natural substances requiring a prescription, due in part to the efforts of Dr. Swetlikoff.

Naturally Splendid Executive Vice President of Marketing & Innovation Bryan Carson states, “I would like to personally welcome Dr. Swetlikoff to the Naturally Splendid Team in general and even more significantly, to the position of Medical Advisor, whose role will include the continued development of the NATERA FX line of products and distribution channels. It is an immense honour to have Dr. Swetlikoff endorse our recently launched NATERA FX line of practitioner grade, hemp-based, therapeutic healthcare products”.

Dr. Swetlikoff states, “It has been a pleasure to observe the development of the NATERA FX(TM) therapeutic line and to witness the commitment to quality that has been insisted upon. This will be the first appointment of this kind that I have accepted and it is due in large part to the quality of product Naturally Splendid has insisted upon, in combination with being on the cutting edge of product development in the area of hemp and cannabinoid extraction specifically for the healthcare practitioner market. I look forward to several more equally as successful product launches as the recent launch at the British Columbia Naturopathic Association’s (BCNA’s) Advancing Naturopathic Medicine 2018 Exhibition in Vancouver recently, that I was an active participant in”.

Dr. Swetlikoff values continuous education in the field of medicine and holds many special certifications in alternative health treatments such as anti-aging therapy, chelation therapy, neural therapy, orthomolecular therapy,
ozone therapy and many other diploma and certificate programs in diagnosis and treatment technologies. Dr. Swetlikoff is an active professional member with leading professional medical organizations including American College for Advancement in Medicine, American Academy of Anti-Aging Medicine, Institute For Functional Medicine, and the Occidental Institute.

Industry officials and peers have acknowledged Dr. Swetlikoff as a leader in the field of naturopathic medicine. Dr. Swetlikoff has written for various newspapers including CBC Health Online, and is a respected lecturer and speaker on alternative health care in Canada.

About Naturally Splendid Enterprises Ltd.

Naturally Splendid is a biotechnology and consumer products company that is developing, producing, commercializing, and licensing an entirely new generation of plant-derived, bioactive ingredients, nutrient dense foods, and related products. Naturally Splendid is building an expanding portfolio of patents (issued and pending) and proprietary intellectual property focused on the commercial uses of industrial hemp and marijuana cannabinoid compounds in a broad spectrum of applications.

For more information e-mail info@naturallysplendid.com or call Investor Relations at 604-673-9573

On Behalf of the Board of Directors

Mr. Douglas Mason

CEO, Director

Contact Information

Naturally Splendid Enterprises Ltd.

(NSP – TSX Venture; NSPDF – OTCQB; 50N Frankfurt)

#108-19100 Airport Way

Pitt Meadows, BC, V3Y 0E2

Office: (604) 465-0548

Fax: (604) 465-1128

E-mail: info@naturallysplendid.com

Website: www.naturallysplendid.com

Forward-Looking Statements

Information set forth in this news release contains forward-looking statements that are based on assumptions as of the date of this news release. These statements reflect management’s current estimates, beliefs, intentions and expectations. They are not guarantees of future performance. Naturally Splendid cautions that all forward looking statements are inherently uncertain and that actual performance may be affected by a number of material factors, many of which are beyond Naturally Splendid’s control including, Naturally Splendid’s ability to compete with large food and beverage companies; sales of any potential products developed will be profitable; sales of shelled hemp seed will continue at existing rates or increase; the ability to complete the sales of all bulk hemp seed purchase orders; and the risk that any of the potential applications may not receive all required regulatory or legal approval. Accordingly, actual and future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward-looking information. Except as required under applicable securities legislation, Naturally Splendid undertakes no obligation to publicly update or revise forward-looking information.

NEITHER TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

Click here to connect with Naturally Splendid (TSXV:NSP) for an Investor Presentation.

Source: www.thenewswire.com

American cannabis sales hit US$17.5 billion in 2020, a research group’s new study shows.

Meanwhile, a Canadian cannabis producer began offering CBD beverages in the US, another move that shows how interested Canadians are in the overall US cannabis market at the moment.

Keep reading... Show less

An Emerging Markets Sponsored Commentary

Some pretty important news out of health and wellness; beverage and natural products company BevCanna Enterprises Inc. (CSE:BEV, Q:BVNNF, FSE:7BC) this week. For those of you following the Company with us, stay tuned.

Keep reading... Show less

As investors continue to prioritize cannabis opportunities in the US, market watchers expect mergers and acquisitions (M&A) to play a role in the future for Canadian companies.

A consolidation trend has been expected in the Canadian cannabis space for some time now based on the size of the market compared to the number of operations in the country.

Keep reading... Show less

The product will include polyphenols known to have significant health benefits.

BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) has reached an important milestone in its development program of additional Nutraceuticals. The olive-based Nutraceutical product scheduled for market availability in the second half of 2022 will contain the following unique matrix of polyphenols: hydroxytyrosol, trosol, and verbascoside. These compounds are the major polyphenols in naturally grown olives and are responsible for the high antioxidant activity of olives and olive oil. Importantly, the BioHarvest olive-based Nutraceutical product will provide all the benefits of olives and olive oil with a low calorie count per serving.

Keep reading... Show less

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it will report financial results for the fourth quarter and full year ended December 31 st , 2020 on Thursday March 25 th , 2021 before the market opens.

The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights on Thursday March 25 th , 2021 at 8:30am Eastern Time (7:30am Central Time).

Keep reading... Show less